Cargando…
Plasma-Derived Exosomal ALIX as a Novel Biomarker for Diagnosis and Classification of Pancreatic Cancer
BACKGROUND: Pancreatic cancer (PC) has a dismal prognosis due to its insidious early symptoms and poor early detection rate. Exosomes can be released by various cell types and tend to be a potential novel biomarker for PC detection. In this study, we explored the proteomic profiles of plasma exosome...
Autores principales: | Yang, Jie, Zhang, Yixuan, Gao, Xin, Yuan, Yue, Zhao, Jing, Zhou, Siqi, Wang, Hui, Wang, Lei, Xu, Guifang, Li, Xihan, Wang, Pin, Zou, Xiaoping, Zhu, Dongming, Lv, Ying, Zhang, Shu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131866/ https://www.ncbi.nlm.nih.gov/pubmed/34026608 http://dx.doi.org/10.3389/fonc.2021.628346 |
Ejemplares similares
-
Analysis of T‐cell receptor repertoire in peripheral blood of patients with pancreatic cancer and other pancreatic diseases
por: Wang, Hui, et al.
Publicado: (2021) -
Heparanase activates the syndecan-syntenin-ALIX exosome pathway
por: Roucourt, Bart, et al.
Publicado: (2015) -
ALIX- and ESCRT-III–dependent sorting of tetraspanins to exosomes
por: Larios, Jorge, et al.
Publicado: (2020) -
Alix: A Candidate Serum Biomarker of Alzheimer’s Disease
por: Sun, Yingni, et al.
Publicado: (2021) -
ALDH1A3 Accelerates Pancreatic Cancer Metastasis by Promoting Glucose Metabolism
por: Nie, Shuang, et al.
Publicado: (2020)